Biofrontera Inc. (BFRI)
USD 0.81
(-0.69%)
USD 0.81
(-0.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.13 Million USD | -3045.47% |
| 2022 | -640 Thousand USD | 98.3% |
| 2021 | -37.71 Million USD | -243.25% |
| 2020 | -10.98 Million USD | -0.05% |
| 2019 | -10.98 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -257 Thousand USD | 97.54% |
| 2024 Q1 | -10.43 Million USD | -396.0% |
| 2023 Q3 | -6.34 Million USD | 35.53% |
| 2023 FY | -20.13 Million USD | -3045.47% |
| 2023 Q4 | 3.52 Million USD | 155.6% |
| 2023 Q2 | -9.83 Million USD | -31.55% |
| 2023 Q1 | -7.47 Million USD | -168.51% |
| 2022 Q2 | 7.06 Million USD | 27.06% |
| 2022 Q1 | 5.56 Million USD | 138.34% |
| 2022 FY | -640 Thousand USD | 98.3% |
| 2022 Q4 | -2.78 Million USD | -8.53% |
| 2022 Q3 | -2.56 Million USD | -136.31% |
| 2021 FY | -37.71 Million USD | -243.25% |
| 2021 Q4 | -14.5 Million USD | 9.41% |
| 2021 Q3 | -16.01 Million USD | -337.37% |
| 2021 Q2 | -3.66 Million USD | -3.59% |
| 2021 Q1 | -3.53 Million USD | -1800.0% |
| 2020 Q2 | -3.71 Million USD | 9.55% |
| 2020 FY | -10.98 Million USD | -0.05% |
| 2020 Q4 | -186 Thousand USD | 93.77% |
| 2020 Q3 | -2.98 Million USD | 19.59% |
| 2020 Q1 | -4.1 Million USD | 0.0% |
| 2019 FY | -10.98 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alvotech | -551.73 Million USD | 96.351% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 141.805% |
| Journey Medical Corporation | -3.85 Million USD | -422.476% |
| Dynavax Technologies Corporation | -6.38 Million USD | -215.088% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 85.587% |
| PainReform Ltd. | -9.34 Million USD | -115.443% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -346.756% |
| SCYNEXIS, Inc. | 67.04 Million USD | 130.028% |
| Silver Spike Investment Corp. | 7.34 Million USD | 374.26% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -346.756% |
| Bright Green Corporation | -13.12 Million USD | -53.348% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 90.379% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -155.794% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 207.2% |
| Alpha Teknova, Inc. | -36.78 Million USD | 45.266% |
| Embecta Corp. | 70.4 Million USD | 128.595% |
| Safety Shot Inc | -15.08 Million USD | -33.468% |
| Procaps Group, S.A. | 42.54 Million USD | 147.323% |
| Cosmos Health Inc. | -18.54 Million USD | -8.566% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -549.695% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 147.982% |
| Theratechnologies Inc. | -23.95 Million USD | 15.97% |
| Harrow Health, Inc. | -24.41 Million USD | 17.533% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -316.36% |
| DURECT Corporation | -27.62 Million USD | 27.125% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 1629.711% |
| Cronos Group Inc. | -73.96 Million USD | 72.782% |
| OptiNose, Inc. | -35.48 Million USD | 43.266% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 97.991% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 52.295% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 184.174% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 507.098% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 12838.479% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -220.592% |
| Radius Health, Inc. | -25.79 Million USD | 21.946% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -226.64% |
| ProPhase Labs, Inc. | -16.78 Million USD | -19.956% |
| Phibro Animal Health Corporation | 2.41 Million USD | 933.237% |
| Procaps Group S.A. | 42.54 Million USD | 147.323% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -95.865% |
| Viatris Inc. | 54.7 Million USD | 136.803% |
| Rockwell Medical, Inc. | -8.43 Million USD | -138.547% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -27.058% |
| SIGA Technologies, Inc. | 68.06 Million USD | 129.574% |
| Tilray Brands, Inc. | -244.98 Million USD | 91.783% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 267.577% |
| Shineco, Inc. | -22.44 Million USD | 10.326% |
| PetIQ, Inc. | 2.13 Million USD | 1044.674% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -367.963% |
| Incannex Healthcare Limited | -18.45 Million USD | -9.058% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 108.062% |
| Alimera Sciences, Inc. | -20.13 Million USD | 0.005% |
| Assertio Holdings, Inc. | -331.94 Million USD | 93.935% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -205.352% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -146.607% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -12.47% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -0.367% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 87.44% |
| Hempacco Co., Inc. | -13.12 Million USD | -53.366% |
| Talphera, Inc. | -18.39 Million USD | -9.425% |
| Alvotech | -551.73 Million USD | 96.351% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 156.481% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 106.163% |
| Currenc Group, Inc. | -15.3 Million USD | -31.519% |
| Kamada Ltd. | 8.28 Million USD | 343.011% |
| Indivior PLC | 2 Million USD | 1106.55% |
| Evoke Pharma, Inc. | -7.79 Million USD | -158.345% |
| Flora Growth Corp. | -57.03 Million USD | 64.705% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -0.367% |
| Evolus, Inc. | -61.68 Million USD | 67.365% |
| HUTCHMED (China) Limited | 100.78 Million USD | 119.975% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 114.636% |
| Akanda Corp. | -32.27 Million USD | 37.627% |